Terms: = Brain cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
46 results:
1. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract] [Full Text] [Related]
2. BRCAness of brain lesions reflects a worse outcome for patients with metastatic breast cancer.
Ishizuka Y; Horimoto Y; Eguchi H; Murakami F; Nakai K; Onagi H; Hayashi T; Ishikawa T; Arai M; Watanabe J
Breast Cancer Res Treat; 2024 Jan; 203(1):49-55. PubMed ID: 37728693
[TBL] [Abstract] [Full Text] [Related]
3. Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas.
Ye L; Tong S; Wang Y; Wang Y; Ma W
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9857-9876. PubMed ID: 37248320
[TBL] [Abstract] [Full Text] [Related]
4. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
5. Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia.
Widiasari NPA; Rai IBN; Dwi Kusumawardani IAJ; Sajinadiyasa IGK; Candrawati NW; Arisanti NLPE
Rom J Intern Med; 2023 Mar; 61(1):63-71. PubMed ID: 36453446
[No Abstract] [Full Text] [Related]
6. Phosphoproteomic Analysis Defines BABAM1 as mTORC2 Downstream Effector Promoting DNA Damage Response in Glioblastoma Cells.
Kalpongnukul N; Bootsri R; Wongkongkathep P; Kaewsapsak P; Ariyachet C; Pisitkun T; Chantaravisoot N
J Proteome Res; 2022 Dec; 21(12):2893-2904. PubMed ID: 36315652
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast cancer.
Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
[TBL] [Abstract] [Full Text] [Related]
8. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
Gu T; Ren J; Hu Z; Wei Y; Huang J
Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
[TBL] [Abstract] [Full Text] [Related]
9. Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma.
Yim E; Leung D
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675963
[TBL] [Abstract] [Full Text] [Related]
10. Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast cancer Treated with Olaparib Monotherapy.
Wang X; Hu N; Cui L; Si Y; Yue J; Zheng F; Kang Y; Yuan P
Curr Cancer Drug Targets; 2022; 22(6):530-536. PubMed ID: 35156571
[TBL] [Abstract] [Full Text] [Related]
11. The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study.
Meimand SE; Pour-Rashidi A; Shahrbabak MM; Mohammadi E; Meimand FE; Rezaei N
World Neurosurg; 2022 Jan; 157():e123-e128. PubMed ID: 34607064
[TBL] [Abstract] [Full Text] [Related]
12. Identification and validation of RNA-binding protein-related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma.
Chen Z; Wu H; Yang H; Fan Y; Zhao S; Zhang M
Cancer Med; 2021 Oct; 10(20):7418-7439. PubMed ID: 34482648
[TBL] [Abstract] [Full Text] [Related]
13. Mutations in
Fasching PA; Yadav S; Hu C; Wunderle M; Häberle L; Hart SN; Rübner M; Polley EC; Lee KY; Gnanaolivu RD; Hadji P; Hübner H; Tesch H; Ettl J; Overkamp F; Lux MP; Ekici AB; Volz B; Uhrig S; Lüftner D; Wallwiener M; Müller V; Belleville E; Untch M; Kolberg HC; Beckmann MW; Reis A; Hartmann A; Janni W; Wimberger P; Taran FA; Fehm TN; Wallwiener D; Brucker SY; Schneeweiss A; Hartkopf AD; Couch FJ
J Clin Oncol; 2021 May; 39(15):1619-1630. PubMed ID: 33780288
[TBL] [Abstract] [Full Text] [Related]
14. Low levels of brca1 protein expression predict a worse prognosis in stage I-II colon cancer.
Du C; Peng Y; He Y; Chen G; Chen H
Int J Biol Markers; 2021 Mar; 36(1):47-53. PubMed ID: 33583275
[TBL] [Abstract] [Full Text] [Related]
15. Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: a case report.
Wang Q; Zhang F; Gao H; Xu Y
Ann Palliat Med; 2021 Jan; 10(1):818-827. PubMed ID: 33545804
[TBL] [Abstract] [Full Text] [Related]
16. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract] [Full Text] [Related]
17. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
18. Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma.
Liu Z; Zhang J
BMC Neurol; 2020 Jun; 20(1):259. PubMed ID: 32600353
[TBL] [Abstract] [Full Text] [Related]
19. Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma.
Chan AM; Enwere E; McIntyre JB; Wilson H; Nwaroh C; Wiebe N; Ou Y; Liu S; Wiedemeyer K; Rambau PF; Grevers X; Morris DG; Neri P; Gilks CB; Visser F; Le N; Luo L; Cook LS; Köbel M
J Pathol Clin Res; 2020 Oct; 6(4):252-262. PubMed ID: 32391646
[TBL] [Abstract] [Full Text] [Related]
20. Large B-cell lymphoma of the uvea: Histopathologic variants and clinicopathologic correlation.
Valenzuela J; Yeaney GA; Hsi ED; Azzato EM; Peereboom DM; Singh AD
Surv Ophthalmol; 2020; 65(3):361-370. PubMed ID: 31676312
[TBL] [Abstract] [Full Text] [Related]
[Next]
